• <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
    来宝网Logo

    热门词:生物显微镜 水质?#27835;?#20202; 微波消解 荧光定量PCR 电化学工作站 生物安全柜

    现在位置首页>技术资料首页>行业动态>行业动态>干细胞治疗市场研究报告

    干细胞治疗市场研究报告

    互联网2009年5月12日 15:09 点击:2015

    干细胞治疗市场研究报告——Stem Cell Therapeutics Markets
     

    Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two branches of American government, along with scientific developments and the competition of world markets presages good market conditions for stem cell research.

     

    With their ability to differentiate and become an ongoing source of cells that make up critical tissues and organs, stem cells have potential for new regenerative therapies and as new research tools for drug developers to test emerging therapies on diseased cells.

    While companies have found opportunity outside the U.S., President Bush's seven year limitations on embryonic stem cell research in the U.S. has limited the U.S. market. Changes in U.S. policy should open up U.S. markets. For market-watchers in the pharmaceutical industry, the question is what potential they have and where they could take the market. Kalorama Information has tackled that question in Stem Cells Therapeutics Markets. Kalorama analyst Alison Sahoo has built models to determine the best case and most likely case scenarios for therapeutic markets for stem cells in the coming years. This report breaks down forecasted revenues and procedure volumes for stem cell technologies for these segments in the following disease areas:

    • Cardiovascular disease
    • Lung disease
    • Arthritis
    • Incontinence
    • Osteoporosis
    • Diabetes
    • Cancer
    • Orthopedics
    • Infertility
    • Alzheimer’s disease
    • Burns (severe)
    • Lupus
    • Parkinson’s disease
    • Liver failure
    • Multiple sclerosis
    • Critical limb ischemia
    • Crohn's disease
    • Sickle cell disease
    • Multiple myeloma
    • NH lymphoma
    • Leukemia

    Ths report is the result of exclusive interviews with executives in the stem cell industry, a review of medical and company literature, government databases and publications. As part of this comprehensive analysis of stem cell markets, the following companies were profiled:

    • Aastrom Biosciences
    • Advanced Cell Technologies
    • Brainstorm Cell Therapeutics
    • Celegene
    • ES Cell International
    • Medistem
    • Neostem
    • Opexa Therapeutics
    • Osiris Therapeutics
    • Plureon
    • Regenetech
    • Revivicor
    • Stem Cell Sciences
    • StemLifeLine
    • ThermoGenesis
    • VetCell Bioscience

    目录及图表

    TABLE OF CONTENTS

    CHAPTER ONE: EXECUTIVE SUMMARY

    • Recent Developments
    • Introduction
    • Current Stem Cell Therapies
    • Developmental Stem Cell Therapies
    • Issues in Stem Cell Research
    • Stem Cell Forecasts
    • Market Forecast
    • The Promise of Stem Cells in Medical Treatment
    • Types of Stem Cells
    • Embryonic Stem Cells
    • Important Developments in ES Cell Research
    • Adult Stem Cells
    • Important Developments
    • Scope and Methodology

    CHAPTER TWO: CURRENT STEM CELL THERAPIES

    • Cancer
    • Leukemia
    • Gene Therapy
    • Multiple Myeloma
    • Non-Hodgkin’s Lymphoma Noncancerous Diseases
      • Aplastic Anemia
      • Immunodeficiency
      • Lupus
      • Sickle Cell Disease
      • Other Conditions

    CHAPTER THREE: DEVELOPMENTAL STEM CELL THERAPIES

    • Alzheimer’s Disease
    • Arthritis
    • Burns
    • Cancer
    • Cardiovascular Conditions
    • Critical Limb Ischemia
    • Crohn’s Disease
    • Diabetes
    • Incontinence
    • Infertility
    • Liver Failure
    • Lung Disease
    • Multiple Sclerosis
    • Orthopedics
    • Osteoporosis
    • Parkinson’s Disease
    • Sickle Cell Disease

    CHAPTER FOUR: STEM CELL MARKET FORECASTS

    • Best Case
      • Forecasts By Disease Area
      • Alzheimer’s Disease
      • Arthritis
      • Burns
      • Cancer,
      • Cardiovascular Conditions
      • Critical Limb Ischemia
      • Crohn’s Disease
      • Diabetes,
      • Incontinence
      • Infertility,
      • Liver Failure
      • Lung Disease
      • Multiple Sclerosis
      • Orthopedics
      • Osteoporosis
      • Parkinson’s Disease
      • Sickle Cell Disease
    • Most Likely Case
      • Forecasts By Disease Area
      • Alzheimer’s Disease
      • Arthritis
      • Burns
      • Cancer,
      • Cardiovascular Conditions
      • Critical Limb Ischemia
      • Crohn’s Disease
      • Diabetes,
      • Incontinence
      • Infertility,
      • Liver Failure
      • Lung Disease
      • Multiple Sclerosis
      • Orthopedics
      • Osteoporosis
      • Parkinson’s Disease
      • Sickle Cell Disease

    CHAPTER FIVE: COMPANY PROFILES

    • Aastrom Biosciences
    • Advanced Cell Technologies
    • Athersys
    • Brainstorm Cell Therapeutics
    • Celegene
    • ES Cell International
    • Medistem
    • MultiCell Technologies, Inc.
    • Neostem
    • Nephros Therapeutics, Inc.
    • Opexa Therapeutics
    • Osiris Therapeutics
    • Plureon
    • Regenetech
    • Revivicor
    • Stem Cell Sciences
    • ThermoGenesis
    • VetCell Bioscience

    LIST OF EXHIBITS

     

    CHAPTER ONE: EXECUTIVE SUMMARY

    • Table 1-2: Stem Cell Therapeutics Market in $ Millions, 2007-2020

    CHAPTER TWO: CURRENT STEM CELL THERAPIES

    • Table 2-1: Types of Leukemia, 2007

    CHAPTER THREE: DEVELOPMENTAL STEM CELL THERAPIES

    • Table 3-1: Global Disease Populations Addressed by Potential Stem Cell Therapies, 2007

       

    • Table 3-2: Estimated and Projected World Cancer Incidence by Selected Types of Cancer, 2007 and 2020

       

    • Table 3-3: Estimated and Projected World Cancer Mortality by Selected Types of Cancer, 2007 and 2020

       

    • Table 3-4: Types and Features of Urinary Incontinence, 2007

       

    • Table 3-5: Types and Causes of Male Infertility, 2007

       

    • Table 3-6: Common Diseases of the Lungs, 2007

    CHAPTER FOUR: STEM CELL MARKET FORECASTS

       

    • Table 4-1: Persons Affected by Key Stem Cell Therapeutic Targets in Millions, 2007

       

    • Table 4-2: Best Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2007 - 2020(Alzheimer’s Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn’s Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson’s Disease, Sickle Cell Disease)

       

    • Table 4-3: Best Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2007 - 2020(Alzheimer’s Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn’s Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson’s Disease, Sickle Cell Disease)

       

    • Table 4-4: Most Likely Case: Procedure Volume for Proprietary Stem Cell Therapies by Disease in Millions, 2007 - 2020(Alzheimer’s Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn’s Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson’s Disease, Sickle Cell Disease)

       

    • Table 4-5: Most Likely Case: Revenues for Proprietary Stem Cell Therapies by Disease in $ Millions, 2007-2020(Alzheimer’s Disease, Arthritis, Burns, Cancer, Cardiovascular Conditions, Critical Limb Ischemia, Crohn’s Disease, Diabetes, Incontinence, Infertility, Liver Failure, Lung Disease, Multiple Sclerosis, Orthopedics, Osteoporosis, Parkinson’s Disease, Sickle Cell Disease)

    CHAPTER FIVE: COMPANY PROFILES

    • Table 5-1: Therapeutic Focus of Selected Stem Cell Therapeutics Companies, 2007
    (来源: 互联网 )


    全年征稿 / 资讯合作

    联系邮箱:[email protected]

    版权与免责声明

    • 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, http://www.67994619.com,违反者本网将追究相关法律责任。
    • 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
    • 如涉及作品内容、版权?#20219;?#39064;,请在作品发表之日起一周内与本网联系,否则视为?#29260;?#30456;关权利。


    云南11选5技巧
  • <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
  • <div id="y09gn"></div>
  • <li id="y09gn"></li>
    <dl id="y09gn"></dl>
    <div id="y09gn"><s id="y09gn"></s></div>
    法甲射手 排列三走势图南方双彩网带连线 fjtc31选7走势图 每晚3d试机号 浙江20选5预测号码 大乐透历史开奖号码 京东彩票 辽宁省体彩十一选五 吉林11选5手机板 河北快3开奖走势图查询 元平特殊教育学校官网 快3走势图今天 东方6十1开奖结果今天 快彩北京11选5 浙江11选5开奖结果查询